ZA956419B - Pharmaceutical compound - Google Patents
Pharmaceutical compoundInfo
- Publication number
- ZA956419B ZA956419B ZA956419A ZA956419A ZA956419B ZA 956419 B ZA956419 B ZA 956419B ZA 956419 A ZA956419 A ZA 956419A ZA 956419 A ZA956419 A ZA 956419A ZA 956419 B ZA956419 B ZA 956419B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceutical compound
- pharmaceutical
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9415617A GB9415617D0 (en) | 1994-08-02 | 1994-08-02 | Pharmaceutical compound |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA956419B true ZA956419B (en) | 1996-02-02 |
Family
ID=10759297
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA956419A ZA956419B (en) | 1994-08-02 | 1995-08-01 | Pharmaceutical compound |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0775122A1 (en) |
JP (1) | JP2696082B2 (en) |
KR (1) | KR970704706A (en) |
AU (1) | AU3182195A (en) |
CA (1) | CA2194567A1 (en) |
GB (1) | GB9415617D0 (en) |
WO (1) | WO1996004257A1 (en) |
ZA (1) | ZA956419B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI9600165A (en) * | 1996-05-21 | 1997-12-31 | Krka Tovarna Zdravil D D Novo | Process for preparation of biological active derivative of 1,2,4- triazole and intermediates useful in this process |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE58738B1 (en) * | 1984-09-05 | 1993-11-03 | Ici Plc | Antifungal azole compounds |
TW211006B (en) * | 1990-08-24 | 1993-08-11 | Mochida Pharm Co Ltd | |
JP2630877B2 (en) * | 1990-08-24 | 1997-07-16 | 持田製薬株式会社 | Optically active triazole derivatives and compositions |
-
1994
- 1994-08-02 GB GB9415617A patent/GB9415617D0/en active Pending
-
1995
- 1995-08-01 AU AU31821/95A patent/AU3182195A/en not_active Abandoned
- 1995-08-01 ZA ZA956419A patent/ZA956419B/en unknown
- 1995-08-01 EP EP95927813A patent/EP0775122A1/en not_active Withdrawn
- 1995-08-01 KR KR1019970700632A patent/KR970704706A/en not_active Application Discontinuation
- 1995-08-01 JP JP7226940A patent/JP2696082B2/en not_active Expired - Lifetime
- 1995-08-01 WO PCT/GB1995/001816 patent/WO1996004257A1/en not_active Application Discontinuation
- 1995-08-01 CA CA002194567A patent/CA2194567A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP0775122A1 (en) | 1997-05-28 |
KR970704706A (en) | 1997-09-06 |
WO1996004257A1 (en) | 1996-02-15 |
JP2696082B2 (en) | 1998-01-14 |
GB9415617D0 (en) | 1994-09-21 |
JPH08183780A (en) | 1996-07-16 |
AU3182195A (en) | 1996-03-04 |
CA2194567A1 (en) | 1996-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA951180B (en) | Pharmaceutical compounds | |
GB9423542D0 (en) | Pharmaceutical compounds | |
ZA954226B (en) | Pharmaceutical compounds | |
GB9502861D0 (en) | Pharmaceutical compounds | |
GB2286394B (en) | Pharmaceutical compounds | |
GB9426224D0 (en) | Pharmaceutical compounds | |
ZA957607B (en) | Pharmaceutical compounds | |
GB9417102D0 (en) | Pharmaceutical compounds | |
GB9426071D0 (en) | Pharmaceutical compounds | |
GB9426080D0 (en) | Pharmaceutical compounds | |
ZA951175B (en) | Pharmaceutical compounds | |
ZA956419B (en) | Pharmaceutical compound | |
GB9426091D0 (en) | Pharmaceutical compound | |
GB9514485D0 (en) | Pharmaceutical compound | |
GB9406473D0 (en) | Pharmaceutical compound | |
GB9417513D0 (en) | Pharmaceutical compounds | |
GB9417322D0 (en) | Pharmaceutical compounds | |
GB9406052D0 (en) | Pharmaceutical compounds | |
ZA944689B (en) | Pharmaceutical compounds | |
ZA941781B (en) | Pharmaceutical compounds | |
SG32534A1 (en) | Pharmaceutical compounds | |
SG32533A1 (en) | Pharmaceutical compounds | |
GB9402889D0 (en) | Pharmaceutical compounds | |
GB9417526D0 (en) | Pharmaceutical compounds | |
GB9417514D0 (en) | Pharmaceutical compounds |